TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

Pennant Investors, LP's Holding History (CIK: 0001759176)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 55,800 Value ($000) $459 Avg Close $6.73 Range $5.12 - $8.38
Q4 2023
Shares 55,800 Value ($000) $502 Avg Close $7.28 Range $5.25 - $9.70